The Latest
Image
ALEXANDRIA, Virginia — Conquer Cancer®, the ASCO Foundation, in collaboration with the Lobular Breast Cancer Alliance, has awarded two grants to support innovative research focused on improving treatment and care for patients with invasive lobular carcinoma (ILC).
The two recipients of the Lobular Breast Cancer Alliance Invasive Lobular Carcinoma Research Grants are:
Image
For centuries, physician-scientists have been studying and treating cancer, yet the question persists: Why haven’t we cured it yet?
Misunderstandings about what it means to cure cancer are driven by a variety of historical and sociocultural factors that have shaped public perception over time. However, there’s an important difference between curing cancer and eradicating it—one that can reshape the idea of what conquering cancer truly means.
Image
ALEXANDRIA, Va. — Conquer Cancer®, the ASCO Foundation, is pleased to award Elizabeth Stover, MD, the 2024 Conquer Cancer – Susan & Teresa Schwab Ovarian Cancer Research Foundation Advanced Clinical Research Award in Ovarian Cancer Research.
Dr. Stover received the award for her research “A Phase 1b study of BCL-XL degrader DT2216 in combination with weekly paclitaxel in recurrent platinum-resistant ovarian cancer.”
Image
ALEXANDRIA, Va. — Conquer Cancer®, the ASCO Foundation, is pleased to announce the recipients of its 2024 Quality Care Symposium Merit Awards.
These distinguished awards recognize first authors on top-ranking abstracts selected for presentation at the ASCO Quality Care Symposium on September 27–28, 2024, in San Francisco, CA.
These 29 oncology professionals are recognized for their respective field and research advancements within the cancer care community:
Image
This article originally appeared online in Impact magazine, a publication of Dana-Farber and The Jimmy Fund.
Longtime Dana-Farber supporter Conquer Cancer®, the ASCO Foundation, recently awarded $1.45 million to support seven researchers pursuing projects in a wide range of disease areas.
Image
ALEXANDRIA, Virginia — Conquer Cancer®, the ASCO Foundation, in collaboration with Twisted Pink, has awarded the Twisted Pink Metastatic Breast Cancer Impact Award to Ashley Schreier, DO, MS, for her work studying the impact of immunotherapies on metastatic triple negative breast cancer—the most advanced stage of the disease.
Sign Up For Our Newsletter
Keep up-to-date with Conquer Cancer: Join our online community to receive updates on how our researchers are making groundbreaking discoveries and what you can do to help.
For PR Professionals
Media Contact:
Email: mediateam@asco.org